ECG diagnostics software platform AccurKardia and cardiac medical technology company HeartBeam are joining forces to make AccurKardia's ECG analysis software available on HeartBeam's devices.
HeartBeam's cable-free, 12-lead ECG system captures electrical signals from the heart from three directions to assess arrhythmias.
The platform is designed for portable devices so physicians can identify...
Dozee coming up with AI-powered ECG patch for remote cardiac monitoring
Indian medical device maker Dozee is introducing a new ECG patch device to its portfolio of remote monitoring solutions.
According to a press release, the ECG patch monitors the heart's electrical activity continuously over multiple days. It will help detect arrhythmias and other early signs of cardiac deterioration,...
Cardiac health-monitoring smart toilet seat maker Casana (formerly Heart Health Intelligence) has raised $14 million in a Series A funding round led by General Catalyst and the Outsiders Fund. Also participating was Bemis Manufacturing Company, a toilet seat manufacturer that led the startup's $2.2 million round last April.
In addition to the fundraise, Casana announced that Austin McChord, the...
Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The $375 million deal is expected to close during fiscal Q2 2021.
Bardy's flagship product is the Carnation Ambulatory Monitor, often referred to as the CAM patch. It's a P-wave signal-capturing wearable...
Element Science, a San Francisco startup developing a wearable personal defibrillator, brought in $145.6 million in Series C funding earlier this month. Led by Deerfield Healthcare and Qiming Venture Partners USA, the raise also included new backers Cormorant Asset Management and Invus Opportunities, as well as prior supporters Third Rock Ventures and Google Ventures.
WHAT THEY DO
Headed by CEO,...
Vixiar, a Johns Hopkins spinout marketing a tablet-based point of care system for assessing cardiac filling pressure, has raised $1.5 million in Series A funding. This brings the company’s total funding to $3 million.
New investors Emerald Development Managers and MMG Opportunities contributed to the round, along with existing investor The Maryland Technology Development Corporation (TEDCO),...
A number of digital health devices have recieved FDA 510(k) clearance in the last month, including a number of apps and devices in the cardiac health space. Some clearances are updates to companies that have one or more existing clearances, while some are newly cleared devices. Read on for a roundup of connected ECG sensors, medical device companion apps, and wearable patches.
1. St. Jude Medical...
GE Healthcare and HeartFlow are working together to increase the clinical availability and adoption of HeartFlow FFRct, a proprietary technology that helps clinicians diagnose and treat patients with suspected coronary artery disease.
The goal of the partnership is to increase the clinical availability and adoption of the technology, the partners say.
They announced the collaboration on Thursday...
On Monday, June 5th Apple will present its worldwide developers' conference (WWDC), an annual event where the company announces new features and products it's launching in the near future. While the focus is usually on new iPhones, Macs, or iPads, it wouldn't be out of character for the company to announce news about its various healthcare ventures as well.
After all, it was at WWDC in 2014 that...
BioTelemetry, formerly known as CardioNet, has acquired TelCare, a diabetes management technology company with the distinction of having had the first FDA-cleared, cellular-connected glucometer. BioTelemetry paid $7 million in cash with the potential for additional performance-based earn-outs of up to $5 million, also in cash. Both BioTelemetry and TelCare are veterans of the early days of the...
